Clinical trials: COVID19 Patients
COVID-19
Clinical Study for the Efficacy and Safety of Ropeginterferon Alfa-2b in Adult COVID-19 Patients With Comorbidities
To evaluate the efficacy of subcutaneous ropeginterferon alfa 2b ( P1101 combined with standard of care (SOC) compared with standard care alone in adult COVID-19 patients with comorbidities.
- Trial name
- NCT05808322
- Testing
- Ropeginterferon alfa-2b, SOC
- Where
- Taiwan
- Volunteers
- 60 people
- Sponsor
- National Taiwan University Hospital
COVID-19
Study to Monitor the Occurrence of Viral Variants in Patients With Compromised Immune Systems Being Treated for COVID-19
Sotrovimab binds to a conserved epitope on the severe acute respiratory syndrome coronavirus (SARS-CoV) and SARS-CoV-2 spike protein outside the receptor-binding motif and has been shown to reduce the risk of hospitalization…
- Trial name
- LUNAR (NCT05305651)
- Testing
- Sotrovimab
- Where
- 8 sites in United Kingdom
- Volunteers
- 217 people
- Sponsor
- GlaxoSmithKline
HIV Infections, Covid19
Safety and Immune Response of COVID-19 Vaccination in Patients With HIV Infection
On 11 February 2020, the International Committee for the Classification of Viruses named the disease caused by SAＲS-CoV-2 infection in humans as the new coronavirus pneumonia (coronavirus disease 2019, COVID-19).
- Trial name
- NCT05043129
- Testing
- Biological/Vaccine: SARS-COV-2 VACCINE
- Where
- China
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- The Second Affiliated Hospital of Chongqing Medical University
COVID
COVID-19 Impact on Rheumatic Patients
A study to assess the impact of coronavirus disease 2019 (COVID-19) pandemic on the attitude, behaviour and mental health of rheumatic patients and to compare them with healthy individuals.
- Trial name
- NCT04407299
- Testing
- self-administered structured questionnaire
- Where
- Egypt
- Volunteers
- 360 people
- Sponsor
- Cairo University
COVID-19 Respiratory Infection
Xanthohumol as an Adjuvant Therapy in Critically Ill COVID-19 Patients
It has been well documented that coronavirus COVID-19 disease is associated with massive inflammatory response and cytokine storm. Several medications have been used to ameliorate COVID-19-related inflammation.
- Trial name
- NCT05463393
- Testing
- Xanthohumol - prenylated chalcone extracted from female inflorescences of hop cones (Humulus lupus). Hop-RXn™, BioActive-Tech Ltd, Lublin, Poland; http://xanthohumol.com.pl/
- Where
- Poland
- Volunteers
- 50 people
- Sponsor
- Medical University of Lublin
Covid19
Impact of the COVID-19 Pandemic on Vaccination
The vaccination policy is drawn up in France by the French Minister of Health, who makes public the vaccination schedule after the opinion of the High Authority of Health.
- Trial name
- COVIDVacImpac (NCT04657263)
- Testing
- Vaccine coverage assessment
- Where
- France
- Volunteers
- 500 people
- Sponsor
- University Hospital, Montpellier
Covid19
Semen Analysis Changes in Covid-19 Positivepatients
The viral pandemic of the coronavirus disease 2019 (COVID-19), generated by a novel mutated severe acute respiratory syndrome coronavirus (SARS-CoV-2), has become a serious worldwide public health emergency, evolving…
- Trial name
- NCT04595240
- Testing
- semen analysis
- Where
- Egypt
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- Assiut University
Patient Safety
Health Care Workers' Perception of Patient Safety During COVID-19 Pandemic
Objective: Analyze health care workers' perception of patient safety during the COVID 19 pandemic. Methodology: Analytical cross-sectional observational study, with a quantitative focus on healthcare workers who are working…
- Trial name
- NCT04576299
- Testing
- Group 1
- Where
- 4 sites in Chile, Colombia and 2 more
- Volunteers
- 260 people, healthy volunteers welcome
- Sponsor
- Universidad Miguel Hernandez de Elche
SARS-CoV2 Infection, COVID-19 Acute Respiratory Distress Syndrome
Impact of COVID-19 SARS-CoV-2 Variability in ICU Hospitalized Patients With Severe Disease
Background:The impact of the emergence of SARS-CoV-2 variants on the severity and clinical outcomes of COVID-19 is controversial.
- Conditions
- SARS-CoV2 Infection, COVID-19 Acute Respiratory Distress Syndrome, Mutation
- Trial name
- SEVARVIR (NCT05162508)
- Testing
- Nasopharyngeal swab
- Where
- France
- Volunteers
- 2,000 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Covid19
Safety and Efficacy of Niclosamide in Patients With COVID-19 With Gastrointestinal Infection
This is a 2-part, 2-arm, Phase 2 , multicentre, randomized, double-blind, placebo-controlled study in adults with COVID-19 with gastrointestinal infection.
- Trial name
- RESERVOIR (NCT04858425)
- Testing
- Niclosamide
- Where
- 25 sites in United States, India and 1 more
- Volunteers
- 166 people
- Sponsor
- Entero Therapeutics
Covid19
Passive Microwave Radiometry (MWR) and AI for COVID-19 Complications Early Diagnostics of Lungs
World Health Organization (WHO) declared COVID-19 it as a global pandemic. It becomes clear that the virus spreading mostly deadly due to limited to access to diagnostics tests and equipment.
- Trial name
- NCT04568525
- Testing
- Passive Microwave Radiometry
- Where
- Kyrgyzstan
- Volunteers
- 195 people
- Sponsor
- Kyrgyz State Medical Academy
Corona Virus Infection, Pregnancy; Infection
THE RELATIONSHIP OF CRP/ALBUMIN RATIO LEVEL AND PROGNOSIS IN PREGNANT COVID-19 PATIENTS
The CRP/albumin ratio (CAR) is a recently defined parameter which represents the ratio of a positive acute phase reactant to a negative acute phase reactant.
- Trial name
- NCT05242172
- Testing
- CRP/Albumin ratio
- Where
- Turkey (Türkiye)
- Volunteers
- 127 people
- Sponsor
- Adiyaman University Research Hospital
Covid19, Respiratory Function Loss
Effect of Respiratory Exerciser on Pulmonary Functions of COVID-19 Patients
COVID-19 infection is the cause of the current pandemic, responsible for loss of life and disability at a rate unseen before. Among survivors, the infection may cause lasting damage, such as permanent loss of lung function.
- Conditions
- Covid19, Respiratory Function Loss, Coronavirus Infection, Pneumonia, Viral
- Trial name
- NCT04826731
- Testing
- Incentive Spirometer/Respiratory Exerciser
- Where
- Turkey (Türkiye)
- Volunteers
- 14 people
- Sponsor
- Diskapi Yildirim Beyazit Education and Research Hospital
Ozone Therapy for Covid 19 Pneumonia Patients
Evaluation of Post-covid 19 Patients Who Receive Ozonetheraphy With Thorax CT
It is known that enhances wound healing by oxidative stress and supports immune system besides it is cheap and has not any side effects.
- Trial name
- NCT04789395
- Where
- Turkey (Türkiye)
- Volunteers
- 25 people
- Sponsor
- Gaziosmanpasa Research and Education Hospital
Oropharyngeal Dysphagia, COVID-19
Oropharyngeal Dysphagia in Patients With COVID-19
Background: Oropharyngeal dysphagia (OD) is a common complication in/post ICU patients that have been with intubation/mechanical ventilation or with tracheotomies or NG tubes, in patients with acute respiratory…
- Conditions
- Oropharyngeal Dysphagia, COVID-19, Sars-CoV2, Nutrition
- Trial name
- NCT04346212
- Testing
- Swallowing evaluation with the EAT-10 and the volume-viscosity swallowing test (V-VST)
- Where
- Spain
- Volunteers
- 605 people
- Sponsor
- Hospital de Mataró
COVID-19
Effect of Combined Use of Ivermectin and Colchicine in COVID-19 Patients
The aim of this study will be to investigate the efficacy of use of combination of Ivermectin and colchicine on severity and outcome Of COVID 19 infection.
- Trial name
- NCT05246072
- Testing
- Ivermectin + colchicine, Colchicine
- Where
- Egypt
- Volunteers
- 135 people
- Sponsor
- Ain Shams University
Covid19
Study of F-652 (IL-22:IgG2 Fusion Protein) in Patients With Moderate to Severe COVID-19
This is an interventional, multicenter, 2-arm, parallel-group, randomized, double-blind, placebo controlled, dose-escalation, safety and efficacy study of F-652 treatment versus placebo in patients aged 18 years or older with a…
- Trial name
- NCT04498377
- Testing
- F-652
- Where
- United States
- Volunteers
- 1 people
- Sponsor
- EVIVE Biotechnology
COVID-19
Famotidine Outpatient COVID-19 Treatment Study
A retrospective case series of patients who self-medicated with Famotidine during coronavirus disease 2019 (COVID-19). The study will collect de-identified patient reported outcome measures of patients with confirmed COVID-19 who…
- Trial name
- NCT04389567
- Testing
- Famotidine
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- Northwell Health
Viral Pneumonia
Multiplex PCR for Severe Respiratory Infections During the COVID-19 Pandemic
The hypothesis was that a retrospective investigation of the molecular virological tests in a University hospital could be informative, with the aim to identify non-COVID-19 respiratory viruses during the circulation of…
- Trial name
- VirCoV+ (NCT06349707)
- Testing
- other: Observational
- Where
- France
- Volunteers
- 18 people
- Sponsor
- Central Hospital, Nancy, France
Exploring Risk Assessment and Recovery From COVID-19 Infection in Hospitalised Patients
COVID19-OR (SARS-CoV-2): Observation,Risk & Recovery
A novel coronavirus, designated corona virus disease 2019 (COVID-19) has resulted in a Pandemic at the time of writing (27th April) the reported number of confirmed cases exceeding 3 million and over 200000 associated deaths.
- Trial name
- NCT04524520
- Where
- United Kingdom
- Volunteers
- 194 people
- Sponsor
- Western Sussex Hospitals NHS Trust
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.